Acorda Therapeutics Cdt buy StockNews.com
Start price
29.04.23
/
50%
€0.41
Target price
29.04.24
-
Performance (%)
10.78%
End price
30.04.24
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 10.78%. StockNews_com has a follow-up prediction for Acorda Therapeutics Cdt where he still thinks Acorda Therapeutics Cdt is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acorda Therapeutics Cdt | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
In the thread Trading Acorda Therapeutics Cdt
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
07.05.23
07.05.23
-
07.05.24
07.05.24
-22.31%
02.06.23
02.06.23
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.58
31.05.23
31.05.23
-
31.05.24
31.05.24
-18.97%
02.06.23
02.06.23